Company: NCEL
Filing Date: 2025-09-03
Form Type: F-4/A
Source: 0001213900-25-084157
Chunk: 19

Company: NewcelX Ltd.
Filing Date: 2025-09-03
Form: F-4/A
Chunk 19
---
:

| “Art. 3b — Bedingtes Aktienkapital für Mitarbeiter- und Berateroptionen                                                                                                                                                                                                                                                                                                                                                              |     | Art. 3b — Conditional Share Capital for Employee and Advisory Options                                                                                                                                                                                                                                                                                                                        |
| Das Aktienkapital erhöht sich mittels bedingter Kapitalerhöhung um höchstens CHF [27‘000.00] durch Ausgabe von höchstens [450‘000] voll zu liberierenden Namenaktien mit einem Nennwert von je CHF [0.06], durch Ausübung von Optionsrechten, welche zwecks Beteiligung von Mitarbeitern (einschliesslich Geschäftsleitung und Verwaltungsrat) und Beratern der Gesellschaft und/oder deren Tochtergesellschaften eingeräumt werden. |     | The Company‘s share capital will be increased by the issuance of a maximum of [450,000] fully paid in registered shares at a nominal value of CHF [0.06] each which amounts to a maximum increase of CHF [27,000.00], by exercising option rights granted to employees (including members of the management and the board of directors) and advisors of the Company and/or its subsidiaries. |
| […]                                                                                                                                                                                                                                                                                                                                                                                                                                  |     | […]”                                                                                                                                                                                                                                                                                                                                                                                         |

The details of the proposal regarding the amount of shares is provisional. The Board of Directors will determine the final details no later than the morning of the NLS Meeting and will finalize this proposal accordingly, which does not constitute an amendment to the proposal. The maximum amount will be set to allow for coverage of options (including RSUs) currently outstanding and options (including RSUs) to be issued in connection with the Merger Agreement in lieu of current Kadimastem options (including RSUs). 6.Amendment of the Articles regarding Conditional Capital for Shareholders’ Options Explanation:Due to the transactions contemplated by the Merger and the changes to the capital structure as contemplated by Proposal2, the current conditional capital for shareholders’ options requires amendment. In addition, it requires an update as to situations where options may be issued. The Board of Directors further believes that an increase of such capital to the maximum amount permitted by law (i.e., in the amount of one -halfof the new share capital to be calculated following the ordinary capital increase as per the proposals of the Board of Directors herein, less the amount of the conditional share capital for